Histoplasmosis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
{{Histoplasmosis}} | {{Histoplasmosis}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AKI}} | ||
==Overview== | ==Overview== | ||
| Line 15: | Line 15: | ||
*[[Infant|Infants]] | *[[Infant|Infants]] | ||
*[[Immunocompromised]] states | *[[Immunocompromised]] states | ||
*[[AIDS]] Patients with [[CD4]] counts of less than 150 cells/mm³ are at highest risk | *[[AIDS]] Patients with [[CD4]] counts of less than 150 cells/mm³ are at highest risk<ref name="pmid26897068">{{cite journal| author=Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C| title=Histoplasmosis. | journal=Infect Dis Clin North Am | year= 2016 | volume= 30 | issue= 1 | pages= 207-27 | pmid=26897068 | doi=10.1016/j.idc.2015.10.009 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26897068 }}</ref> | ||
*[[Hematological malignancy|Hematologic]] malignancies | *[[Hematological malignancy|Hematologic]] malignancies | ||
*[[Organ transplant|Solid organ transplant]] | *[[Organ transplant|Solid organ transplant]]<ref name="pmid28470019">{{cite journal| author=Natarajan M, Swierzbinski MJ, Maxwell S, Zelazny AM, Fahle GA, Quezado M et al.| title=Pulmonary Histoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Case Report and Review of the Literature. | journal=Open Forum Infect Dis | year= 2017 | volume= 4 | issue= 2 | pages= ofx041 | pmid=28470019 | doi=10.1093/ofid/ofx041 | pmc=5407209 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28470019 }} </ref> | ||
*[[Hematopoietic stem cell transplant]] | *[[Hematopoietic stem cell transplant]] | ||
*Use of [[immunosuppressive agents]] such as [[corticosteroids]] and [[Tumour necrosis factor|tumor necrosis factor]] antagonists | *Use of [[immunosuppressive agents]] such as [[corticosteroids]] and [[Tumour necrosis factor|tumor necrosis factor]] antagonists | ||
| Line 29: | Line 29: | ||
[[Category:Fungal diseases]] | [[Category:Fungal diseases]] | ||
[[Category:Rat carried diseases]] | [[Category:Rat carried diseases]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Pulmonology]] | |||
[[Category:Gastroenterology]] | |||
Latest revision as of 22:11, 29 July 2020
|
Histoplasmosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Histoplasmosis risk factors On the Web |
|
American Roentgen Ray Society Images of Histoplasmosis risk factors |
|
Risk calculators and risk factors for Histoplasmosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]
Overview
Risk factors for histoplasmosis infection include living in or traveling to the Central or Eastern United States. Patients with immunosupression, hematological malignancies, immunosuppressive therapy and infants are at a higher risk of developing disseminated histoplasmosis infection.
Risk Factors
Risk factors for pulmonary histoplasmosis include:
- Living in or traveling to the Central or Eastern United States.
- Activities such as spelunking, mining, construction, excavation, demolition, roofing, chimney cleaning, farming, gardening, and installing heating and air-conditioning systems.
- Activities that expose people to areas where bats live and birds roost also increase risk. Exposure to soil or particles contaminated with droppings of chickens, bats, or blackbirds is the main mode of transmission.[1]
Risk factors for severe acute disease or disseminated disease include:
- Infants
- Immunocompromised states
- AIDS Patients with CD4 counts of less than 150 cells/mm³ are at highest risk[2]
- Hematologic malignancies
- Solid organ transplant[3]
- Hematopoietic stem cell transplant
- Use of immunosuppressive agents such as corticosteroids and tumor necrosis factor antagonists
- Congenital T-cell deficiencies
- Gamma interferon receptor deficiency
- Hyperimmunoglobulin M syndrome is a risk factor for refractory and recurrent disseminated histoplasmosis
References
- ↑ Chiller, TM. Chapter 3 Infectious Diseases Related to Travel. Histoplasmosis. Available at: http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/histoplasmosis. Accessed February 2, 2016.
- ↑ Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C (2016). "Histoplasmosis". Infect Dis Clin North Am. 30 (1): 207–27. doi:10.1016/j.idc.2015.10.009. PMID 26897068.
- ↑ Natarajan M, Swierzbinski MJ, Maxwell S, Zelazny AM, Fahle GA, Quezado M; et al. (2017). "Pulmonary Histoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Case Report and Review of the Literature". Open Forum Infect Dis. 4 (2): ofx041. doi:10.1093/ofid/ofx041. PMC 5407209. PMID 28470019.